← back to search

Jelmar Quist

King's College London · GB
Area of research
Oncology · Genetics
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, and Lung Cancer Treatments and Mutations.
h-index
16
citations
1,003
works
219
NIH funding
primary concept
email

Recent publications

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
Nature Genetics 2022cited by 87position: middledoi
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer
Cancer Research 2021cited by 97position: middledoi
Random Forest Modelling of High-Dimensional Mixed-Type Data for Breast Cancer Classification
Cancers 2021cited by 58position: firstdoi
TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer
Cell Reports Medicine 2021cited by 40position: middledoi
Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases
Nucleic Acids Research 2019cited by 51position: middledoi
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
Nature Communications 2018cited by 57position: middledoi
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer
Nature Medicine 2016cited by 243position: middledoi
Functional and prognostic significance of the genomic amplification of frizzled 6 (<i><scp>FZD6</scp></i>) in breast cancer
The Journal of Pathology 2016cited by 73position: middledoi
Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B
PLoS ONE 2016cited by 36position: middledoi
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Breast Cancer Research 2015cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anita Grigoriadis · King's College London6 papers (2015–2021)Andrew Tutt · Institute of Cancer Research4 papers (2015–2018)Hasan Mirza · Barts Health NHS Trust2 papers (2016–2018)Pierfrancesco Marra · Kings Health Partners2 papers (2016–2018)Franca Fraternali · Institute of Structural and Molecular Biology1 papers (2019–2019) · 1 papers (2016–2016)Matthew J. Smalley · Cardiff University1 papers (2015–2015) · 1 papers (2018–2018)Pier Giorgio Natali · UCLA Medical Center1 papers (2016–2016)Johan Staaf · University of Oslo1 papers (2021–2021) · 1 papers (2016–2016)Ana M. Mendes‐Pereira · Kings Health Partners1 papers (2018–2018) · 1 papers (2016–2016) · 1 papers (2016–2016)Arturo Sala · University of London1 papers (2016–2016)Clare M. Isacke · Institute of Cancer Research1 papers (2015–2015) · 1 papers (2016–2016)Liliana Ordonez · Swansea University1 papers (2015–2015) · 1 papers (2016–2016)Paola Vagnarelli · University of London1 papers (2016–2016)